Neuroprotective role of dopamine against hippocampal cell death

Journal of Neuroscience

Volumn 20, Issue 22, 2000, Pages 8643-8649

  Bozzi, Y ^a   Vallone, D ^a   Borrelli, E ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Apoptosis; Dopamine D2 receptors; Epilepsy; Excitotoxicity; Glutamate receptors; Kainic acid

Indexed keywords

DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR; KAINIC ACID;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INJURY; CELL DEATH; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; EPILEPSY; EVOKED RESPONSE; HIPPOCAMPUS; MESSENGER RNA SYNTHESIS; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL;

EID: 0034668920     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-22-08643.2000     Document Type: Article

References (61)

1. Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro
2. Hippocampal formation
3. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
4. Limbic seizures and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
5. 3H]kainic acid receptor subtypes in the rat hippocampus
6. Glutamate and Parkinson's disease
7. 125I]iodosulpride
8. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: Comparison with dopamine D2 receptor mRNA
9. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas
10. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity
11. Glutamate neurotoxicity and diseases of the nervous system
12. Glutamate receptors and the induction of excitotoxic neuronal death
13. Dopamine agonist treatment of self-induced pattern-sensitive epilepsy. A case report
14. Oxidative stress, glutamate, and neurodegenerative disorders
15. Limbic-cortical neuronal damage and the pathophysiology of schizophrenia
16. BAX is required for neuronal death after trophic factor deprivation and during development
17. Excitatory amino acids and epilepsy
18. Glial changes after an excitotoxic lesion in the CNS. II. Astrocytes
19. Altered gene expression during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
20. Hyperprolactinaemia and temporal lobe epilepsy in a woman: Concomitant and persistent prolactin suppression and temporal lobe epilepsy relief
21. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain
22. Neuroprotective effects of estrogens: Potential mechanisms of action
23. Beyond the dopamine receptor: The DARPP-32/protein phosphatase-1 cascade
24. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding activities
25. Dopaminergic modulation of glutamate-activated channels in the central nervous system
26. Cloned glutamate receptors
27. Dopamine receptors: Molecular biology, biochemistry and behavioral aspects
28. Steroid hormones and excitability in the mammalian brain
29. Upregulation of bax protein levels in neurons following cerebral ischemia
30. Neuroprotection by dopamine agonists
31. Dopamine/glutamate interactions in Parkinson's disease
32. Kainic acid induced limbic seizures: Metabolical, behavioral, electroencephalographic and neuropathological correlates
33. Kainic acid-induced limbic seizures: Electrophysiologic studies
34. Dopamine decreases the calcium-activated after hyperpolarization in hippocampal CA1 pyramidal neurons
35. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis
36. 125I]iodosulpride, a highly selective ligand
37. Excitatory amino acid receptors and their role in epilepsy and cerebral ischemia
38. Differential expression of the jun family members in rat brain
39. Proto-oncogene transcription factors and epilepsy
40. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death
41. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice
42. Dopamine agonists and neuroprotection in Parkinson's disease
43. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia
44. Dopamine selectively inhibits the direct cortical pathway to the CA1 hippocampal region
45. Dopamine changes the shape of action potentials in hippocampal pyramidal cells
46. Kainate-induced apoptotic cell death in hippocampal neurons
47. Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit
48. Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia
49. p53 induction is associated with neuronal damage in the central nervous system
50. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress
51. Genetic determinants of susceptibility to cytotoxic cell death: Implications for gene targeting approaches
52. The molecular biology of mammalian glutamate receptor channels
53. Mutant mice and neuroscience: Recommendations concerning genetic background
54. Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: An in vitro study
55. Regulation of seizure threshold by D1 versus D2 receptors
56. The role of dopamine in epilepsy
57. Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat
58. Regulation of kainate receptor by cAMP-dependent protein kinase and phosphatases
59. Fos induction following systemic kainic acid: Early expression in the hippocampus and later widespread expression correlated with seizure
60. Protein phosphatase 1 modulation of neostriatal AMPA channels: Regulation by DARPP-32 and spinophilin